CurrentUnitedHealthcarePolicy 2025 P 1110-13

Oxford Supply Limits Triptans

Defines quantity-per-copayment and home-delivery ceiling limits for specified triptan products and the clinical criteria under which requests exceeding the limited amount may be approved for Oxford members effective 1/1/2026.

Policy Summary

PayerUnitedHealthcare

PolicyOxford Supply Limits Triptans

Policy CodePolicy 2025 P 1110-13

Change TypeRevised (administrative/product list updates)

Effective DateJan 1, 2026

Next Review DateN/A

Key ActionProvider must supply the number of migraines per month (and indicate if >2 require more than one dose) when requesting quantities exceeding the limited amount; approvals limited to the member's reported monthly migraine count up to the ceiling limit.

SourceLink

POLICY UPDATE CHANGES

Effective Date set for Oxford: 1/1/2026 and program versioning to 10/2025 noted in history.

8Listed Triptan Products

Retail/HomeCeiling Limit Types

2Primary clinical frequency thresholds

Policy summary

Policy: Oxford Supply Limits for Triptans (Program 2025 P 1110-13) — Effective 2026-01-01. Triptans (listed products such as Imitrex nasal/injection, Onzetra Xsail, Tosymra, Zembrace SymTouch, zolmitriptan ODT, Zomig nasal spray) are approved for the acute treatment of migraine with or without aura and are not intended for prophylactic use or for management of hemiplegic or basilar migraine. The policy defines per-copayment quantity limits and ceiling limits (different for retail and home delivery) and establishes clinical criteria for approving quantities above the standard copayment/coinsurance limits for Oxford members.

Approval criteria for quantities above supply limit

Thresholds & definitions

Monthly migraine frequency for increased quantity> 4 migraines/month — allows approval up to the ceiling limit for the number of migraines the member experiences

Monthly migraines requiring more than one dose> 2 migraines/month each requiring more than one dose — allows approval up to the ceiling limit for the number of migraines the member experiences

Definition — Ceiling limitMaximum quantity approved for a request exceeding the limited amount per copayment or coinsurance (different for retail and home delivery by product)

Products subject to supply limit

Products covered under supply limit policy (by product name)mixed

Imitrex (sumatriptan) Nasal Spray	Included in supply limit
Imitrex (sumatriptan) Injection 4 mg and 6 mg syringes	Included in supply limit
Imitrex Injection vials	Included in supply limit
Onzetra Xsail (sumatriptan)	Included in supply limit
Tosymra	Included in supply limit
Zembrace SymTouch (sumatriptan)	Included in supply limit
zolmitriptan ODT	Included in supply limit
Zomig Nasal Spray (zolmitriptan)	Included in supply limit

What providers must do

Documentation Required

Document migraine frequency and dosing needs

When requesting quantities above the limited amount, document the number of migraines the member has per month and indicate if more than two of those migraines require more than one dose. Approvals will only be for treatment of the number of migraines per month reported by the member, up to the policy-defined ceiling limit.

Approvals limited to the member's reported monthly migraine count, up to the ceiling limit.

Prior Authorization

Prior authorization for quantities exceeding supply limit

Prior authorization requests for quantities exceeding the per-copayment/coinsurance limited amount will be approved up to the product-specific ceiling limit only if the clinical criteria are met. UnitedHealthcare may also approve initial requests or reauthorizations based solely on previous claims/medication history, diagnosis codes (ICD-10), and/or claim logic.

Consideration of previous claim/medication history
Relevant diagnosis codes (ICD-10)
Automated claim logic may be used for approval or re-approval

Documentation Required

Physician risk acknowledgement

The physician must acknowledge that the potential benefit of the higher dose or greater quantity outweighs the associated risks when requesting approval above the limited amount.

Clinical and policy context

Triptans are indicated for the acute treatment of migraine with or without aura and are explicitly not for prophylactic therapy or for hemiplegic/basilar migraine. The policy sets supply limits for specified triptan products and allows approval of quantity requests exceeding the limited amount per copayment or coinsurance up to a defined ceiling limit when clinical criteria are met, including a diagnosis of moderate to severe migraine and either > 4 migraines/month or > 2 migraines/month that each require more than one dose; physician acknowledgement of benefit versus risk is also required. UnitedHealthcare may also approve based on prior claims/medication history or diagnosis codes.

Key terms

Definition details

Ceiling limit (term)Maximum quantity approved for a request exceeding the limited amount per copayment or coinsurance (different for retail and home delivery by product).

Examples (retail vs home delivery)Imitrex Nasal Spray: Retail = 2 packs (12 units); Home Delivery = 6 packs (36 units). Imitrex Injection syringes: Retail = 4 kits (8 injections); Home Delivery = 12 kits (24 injections). Onzetra Xsail: Retail = 8 pouches (16 nose pieces); Home Delivery = 24 pouches (48 nose pieces). Zembrace SymTouch: Retail = 8 auto-injectors; Home Delivery = 24 auto-injectors. zolmitriptan ODT: Retail = 8 tablets; Home Delivery = 24 tablets. Zomig Nasal Spray: Retail = 2 packs (12 units); Home Delivery = 6 packs (36 units).

Common questions

To request quantities above the per-copayment limit, providers must document the member’s migraine frequency (number of migraines per month) and indicate if more than two migraines per month require multiple doses; approvals are limited to treatment of the member’s reported monthly migraine count up to the product-specific ceiling limit. The physician must acknowledge that the potential benefit outweighs the risk for the higher dose/quantity. UnitedHealthcare may also consider prior claim/medication history, ICD-10 diagnosis codes, and claim logic when authorizing above-limit quantities. Note that ceiling limits differ by channel (examples: Imitrex nasal spray Retail = 2 packs (12 units) vs Home Delivery = 6 packs (36 units); similar retail and home delivery ceilings apply for other listed triptan products).

Policy changes

10/2025program_versioning

Multiple historical administrative and product list updates through 10/2025; no single recent clinical policy statement change indicated.

2026-01-01effective_dateLatest

Effective Date set for Oxford: 1/1/2026. Multiple historical administrative and product list updates through 10/2025; no single recent clinical policy statement change indicated.